Monges Viviane

Insider profile

Performance

Overall performance
2.5

Performance over holding periods
2.5
30 days 90 days 120 days
Average return -5% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 50% Buy
34 71% Buy
47 69% Buy
Monges Viviane's trades of Pharvaris NV's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-05-26 2026-05-21 S Sale
46,769 +10.2%
233.39
US$4,415,065
46,769 +10.2% 233.39 US$4,415,065
2026-05-21 2026-05-21 PrS Proposed sale
11,273
331.98
US$1,992,417
11,273 331.98 US$1,992,417
2024-06-18 2024-06-17 S Sale
72,413 +36.5%
465.72
US$3,879,865
72,413 +36.5% 465.72 US$3,879,865
2022-06-17 2022-06-14 B Purchase
3,000
13.94
€41,820
3,000 13.94 €41,820
2022-06-17 2022-06-14 B Purchase
8,000
13.86
€110,880
8,000 13.86 €110,880
2022-06-02 2022-05-30 B Purchase
3,750
13.41
€50,288
3,750 13.41 €50,288
2022-05-23 2022-05-23 B Purchase
7,500
13.21
€99,075
7,500 13.21 €99,075
2018-12-18 2018-12-07
BE Ucb SA (UCB)
B Purchase
1,000
74.36
€74,360
1,000 74.36 €74,360